Billcheckly

Check a hospital estimate before admission and the bill before you pay

Consumers

TL;DR Billcheckly helps families who pay for planned surgery out of their own pocket. Before admission, it compares the hospital's written estimate with real estimates and bills that other families have shared. After discharge, it checks the final bill line by line and drafts a dispute letter. Families pay a flat fee and no hospital pays Billcheckly.

The problem

Indian families still foot a big chunk of their own medical bills. Out-of-pocket spending was 39.4% of total health expenditure in 2021-22[1].

The law on hospital pricing exists, but nobody ever finished it. Rule 9 of the Clinical Establishments Rules 2012 asks hospitals to display their rates and charge within a range set by the Centre, and yet in August 2026 the Centre told the Supreme Court that no state had sent a concrete proposal for that range[2].

So families compare hospitals blind and find the extras on the final bill. How bad can the extras get? When Maharashtra's FDA checked hospital consumables, it found printed prices up to 2,841% above purchase cost, with an IV set bought for about ₹11 and printed at ₹325[3].

The idea

First, the important bit - Billcheckly does price information and bill checking only. It gives no medical advice about whether, where or how to get treated, and it does not sell or broker insurance. It handles bills as health data under the DPDP Act[4].

Here's how it works. A family uploads a hospital's estimate for, say, a knee replacement. Billcheckly reads it, breaks it into room, surgeon, implant, consumables and medicines, and sets each line against estimates and bills from other patients in that city and against public anchors such as NPPA ceiling prices for stents and knee implants[5]. After discharge, the same breakdown runs on the final bill. A trained reviewer checks every flag before the family sees it and then drafts a polite letter to the hospital's billing desk.

The original version of this idea pitched AI that gathers prices and negotiates. That falls apart in India. Hospitals don't publish usable price lists, so there's little to gather, and one patient has no clout at a billing counter. Surgery platforms get better rates through volume[6]. A neutral checker backed by real bills is something a single family can actually use.

Who pays

The family pays, and it's often an adult child arranging a parent's planned surgery without enough insurance. My test price is a flat fee per estimate check and a higher one per bill audit, both of them my own assumptions. The alternative today is free though - the big surgery-care platforms offer free consultation booking and say there are no hidden charges[7], but they get paid by the surgeries they route. Employers could offer checks as a benefit later on.

Why now

Rule 9 has been in front of the Supreme Court since 2024, and in August 2026 the Centre was still defending rate ranges there[2][8]. After the Maharashtra FDA findings, the Centre called for a review of consumable prices in September 2026[3]. NPPA revised stent ceilings again from April 2026[5], which gives a bill checker firm numbers to test against.

Market signal

There's no public figure for an Indian bill-audit or price-comparison market. The closest number I could find is one surgery-care platform, which helped with nearly 15,000 surgeries in FY25, worth about ₹150 Cr[6]. That shows families will use a third party to plan surgery.

The 39.4% out-of-pocket share[1] is broader context. It covers all care, so don't mistake it for your market.

Who's already doing this

One surgery-care platform works with hospital partners and financing, and lists transparent pricing as part of its model[6]. A second runs its own and partner hospitals, handles cashless claims and promises no surprise bills[7]. Both earn from the procedures they arrange, so neither of them is going to audit another hospital's bill.

I found no Indian service that does neutral bill checking at consumer prices. That's the gap.

How hard is it?

Difficulty Moderate (39/100)
Starting capital ₹40–80 L
Time to launch 4–6 months

Reading bills is the easy part. The hard part is the price database, because without thousands of real estimates and bills per city your comparisons are thin. You also need reviewers who understand hospital billing and a clear legal line on what you can say about named hospitals.

Licences and approvals

No special licence is needed to check bills, but a few rules shape what you can say and how you handle data.

  • Clinical Establishments Rules 2012, Rule 9. Hospitals must display rates, and the Act applies only in some states while others have their own laws[2]. Check which applies in your launch city before you cite it in a letter.
  • NPPA ceiling prices for stents[5] and knee implants[9] give you lawful anchors. Use only the current notification.
  • DPDP Act compliance before the first upload, because bills reveal diagnoses[4].
  • IRDAI intermediary rules may apply if insurers pay you or you help sell policies [Requires validation].
  • Legal review of dispute letters, because statements about named hospitals carry defamation risk [Requires validation].

Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.

How AI can power this business

  • Bill reading. AI turns a photographed estimate or final bill into clean line items (room, surgeon, implant, consumables, medicines), which saves the reviewer most of the typing.
  • Line-by-line comparison. Each line is set against bills from other patients in the same city and against NPPA caps, so odd charges stand out.
  • Letter drafting. Once a reviewer approves the flags, AI drafts a polite letter to the billing desk for the family to send.
  • Price database upkeep. It can spot duplicate uploads and odd entries before they skew the city benchmarks.

Don't let AI tell a family a charge is wrong without a trained reviewer checking it, and never let it advise on whether or where to get treated.

Want to work out the AI layer for Billcheckly? Talk to Yash →

Biggest risks

Here's what can go south -

  • Thin data. Early comparisons may rest on a handful of bills, and one bad flag will cost you trust.
  • Legal pushback. A hospital may threaten action if you publish or circulate its prices or call a charge excessive.
  • Low willingness to pay. Families may see the service as nice to have until the bill arrives, and by then it is too late.

Our take

I like this one for a founder with hospital billing, TPA or insurance-claims experience who doesn't mind building a consumer brand slowly. If you're expecting fast revenue then skip it.

Before you spend a rupee, prove two things - that 100 families in one city will share real bills, and that at least one in five audits recovers more than the fee.

Questions founders ask

My estimate is ₹40–80 L, mostly for the app, trained reviewers and marketing to build a bill database. The kit breaks it down.

Do I need a licence to start a medical bill audit service in India?

Not a special one. You do need DPDP Act compliance for bills, and if insurers pay you or you sell policies then IRDAI rules may apply.

Can I start a hospital bill checking business in another country?

Yes, where hospital prices are opaque. Pricing laws and health-data rules vary, so check yours before you publish any comparison.

Download the kit

The free Billcheckly validation kit has the line-by-line capital breakdown, the effort scoring, the pricing-rule and data-protection checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for families, and 5 assumptions to test. Download the kit →

Talk to Yash

Thinking about building Billcheckly or something close to it? The make-or-break work is collecting enough real bills to make your comparisons credible, and that's the kind of thing I help founders plan. If you need a hand, you know where to find me. Talk to Yash →

Sources

  1. PIB, "National Health Account Estimates 2020-21 and 2021-22: a comprehensive overview", 2024-10-04. https://static.pib.gov.in/WriteReadData/specificdocs/documents/2024/oct/doc2024104408201.pdf
  2. LiveLaw, "Centre defends Clinical Establishment Rule in Supreme Court", 2026-08-11. https://www.livelaw.in/top-stories/centre-defends-clinical-establishment-rule-in-supreme-court-says-it-curbs-excessive-pricing-of-medical-services-545337
  3. Omnicuris MedShots, "Will new price caps curb inflated hospital consumables?", 2026-09-21. https://www.omnicuris.com/medshots/daily_updates/hospital-consumable-prices-review-india_21-Sep-26_13-06
  4. PRS Legislative Research, "Digital Personal Data Protection Bill 2023", 2023-08. https://prsindia.org/billtrack/digital-personal-data-protection-bill-2023
  5. Medical Dialogues, "NPPA revises coronary stent prices, DES at Rs 39,186 and BMS at Rs 10,762 from April 2026", 2026-04-07. https://medicaldialogues.in/news/industry/medical-devices/nppa-revises-coronary-stent-prices-des-at-rs-39186-and-bms-at-rs-10762-from-april-2026-168192
  6. BioSpectrum India, "HexaHealth closes Series A fund raise of $12 M", 2025-04-30. https://biospectrumindia.com/news/86/26060/hexahealth-closes-series-a-fund-raise-of-12-m-to-redefine-surgical-care-journey-across-india.html
  7. Pristyn Care, official site, accessed 2026-10-17. https://www.pristyncare.com/
  8. LiveLaw, "Why range of rates for hospital services not specified? Supreme Court slams Centre", 2024-02-28. https://www.livelaw.in/amp/top-stories/supreme-court-disparity-healthcare-costs-centre-standard-rates-clinical-establishment-act-250776
  9. Medical Dialogues, "NPPA continues price cap on orthopedic knee replacement implants till November 15, 2026", 2025-11-17. https://medicaldialogues.in/news/industry/medical-devices/nppa-continues-price-cap-on-orthopedic-knee-replacement-implants-for-another-year-till-november-15-2026-158881

For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.

Reviews

No reviews yet